February 24 (SeeNews) - The District Court in Ljubljana has rejected a request by Switzerland’s Novartis for a temporary injunction that would have prohibited Slovenian drug maker Krka from manufacturing and marketing in its home country the product Valsacor over an alleged patent infringement, Krka said on Tuesday.